Stryker Corporation
I · Analyse IA
En bref
Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].
Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].
Stryker is financially robust with excellent margins, strong cash generation, and low leverage.
Score Sentinellis
10/10
Financially healthy
Capitalisation boursière
$121.8B
Chiffre d'affaires (12 mois)
$25.1B
II · Actualités récentes
Ce qui a fait bouger le cours
5 stories · ranked by relevance
- macro2026-05-18
PAHC or SYK: Which Is the Better Value Stock Right Now?
Yahoo Finance
- macro2026-05-19
BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
Yahoo Finance
- macro2026-05-16
Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback
Simply Wall St
- macro2026-05-15
Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating
Yahoo Finance
- macro2026-05-15
Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom
Yahoo Finance
Premium · gratuit avec tout compte
Stryker trades at a PE ratio of 36.8x, which is elevated relative to historical norms and leaves the stock vulnerable to significant correction if earnings disappoint, especially with the next earnings report due July 30, 2026 [Yahoo Finance] [EODHD]
Risques
4
Opportunités
6
Signaux d'alerte
2
Direction
10
21 autres constats dans le rapport complet — gratuit avec tout compte.
Débloquer l'analyse complète de Stryker Corporation
Créez un compte gratuit pour accéder au rapport complet généré par IA, avec les sources citées dans le texte.
- 4 risques, 6 opportunités et 2 signaux d'alerte — chacun avec sa source
- Plus de 100 indicateurs financiers avec graphiques et comparaisons
- Résumés d'actualités complets avec liens vers les sources
- Équipe dirigeante et rémunération
- Export PDF pour la lecture hors ligne
III · Entreprises similaires
À lire également
Same sector · Healthcare or comparable health
L'ajouter à votre liste ?